Although these fore‐mentioned mechanisms are more extensively studied in NEPC, our data showed no correlation between TUBB3 expression and NED in conventional prostate adenocarcinoma, consistent with studies in neuroendocrine lung cancers.26 This evidence concerns the gene TUBB3 and prostate adenocarcinoma.